Registered entities
Tizona Therapeutics, Inc
Reg. No. 5615083United States
Innovation
11 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 582 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 9 |
| 2026 | 1 |
Social engagement
Social engagement: 5K social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include AbbVie, Abingworth, Canaan, Astellas Venture Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 2 | 22% |
Recent activity
7 Nov 2025
Event
SITC25